Department of Clinical Oncology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Clin Oncol (R Coll Radiol). 2018 Apr;30(4):262-268. doi: 10.1016/j.clon.2017.12.021. Epub 2018 Jan 17.
Growth of the cancer incidence rate in Iran has been very high in recent years. Therefore, the Iranian health care system should be prepared for the treatment of a huge number of patients in the foreseeable future. One of the most important treatment options for cancer is radiation. However, there is no comprehensive information on infrastructure for radiation oncology in this country.
In 2015, a questionnaire was designed by the Iranian Society of Clinical Oncology (ISCO) and all radiation oncology centres in the country were visited to determine four important components of radiation oncology services, including facilities, equipment, personnel and patients.
In 2015, 94 radiotherapy centres were identified in Iran. Sixty-one centres were fully operational, six centres were commissioning, 26 centres were under construction and one was inactive. Among the fully operational radiotherapy centres, 54 offered three-dimensional conformal radiotherapy and two-dimensional radiotherapy, eight offered brachytherapy, two intensity-modulated radiotherapy, two intraoperative radiotherapy, ostereotactic radiosurgery, two hyperthermia and 59 chemotherapy. Moreover, the survey identified 110 linear accelerators, 25 cobalt-60, one gamma knife, 21 remote brachytherapy afterloaders and six orthovoltage units. Treatment planning equipment included 15 graphy simulators, 19 dedicated computed tomography simulators, 22 multileaf collimator and 12 electronic portal imaging devices. Moreover, in 2015, 243 clinical oncologists participated in the treatment of 42 350 cancer patients in need of radiotherapy, which is about one radiation oncologist for 175 patients. During 2010-2015, number of cobalt-60 reduced 70%, from 25 units to 8 units.
There is a significant gap between Iran's available facilities for radiation therapy and international standards. Moreover, during international economic sanctions against Iran this gap widened.
近年来，伊朗的癌症发病率增长非常高。因此，伊朗的医疗保健系统应该为未来可预见的大量患者的治疗做好准备。癌症的最重要治疗选择之一是放射治疗。然而，该国没有关于放射肿瘤学基础设施的综合信息。
2015 年，伊朗临床肿瘤学会（ISCO）设计了一份问卷，并访问了该国所有的放射肿瘤学中心，以确定放射肿瘤学服务的四个重要组成部分，包括设施、设备、人员和患者。
2015 年，伊朗共确定了 94 个放射治疗中心。61 个中心全面运作，6 个中心正在调试，26 个中心正在建设中，1 个中心未运作。在全面运作的放射治疗中心中，54 个提供三维适形放射治疗和二维放射治疗，8 个提供近距离放射治疗，2 个调强放射治疗，2 个术中放射治疗，骨转移瘤放射外科治疗，2 个高温治疗和 59 个化疗。此外，该调查还确定了 110 个线性加速器、25 个钴-60、1 个伽玛刀、21 个远程后装近距离放射治疗机和 6 个正交千伏单位。治疗计划设备包括 15 个图形模拟器、19 个专用 CT 模拟器、22 个多叶准直器和 12 个电子射野影像装置。此外，2015 年，243 名临床肿瘤学家参与了 42350 名需要放射治疗的癌症患者的治疗，这意味着每 175 名患者就有一名放射肿瘤学家。2010-2015 年期间，钴-60 的数量减少了 70%，从 25 个减少到 8 个。
伊朗现有的放射治疗设施与国际标准之间存在显著差距。此外，在对伊朗实施国际经济制裁期间，这一差距进一步扩大。
